Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Change in Receivables (2024 - 2025)

Historic Change in Receivables for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Q3 2025 value amounting to $1.2 million.

  • Tonix Pharmaceuticals Holding's Change in Receivables fell 2738.89% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2024, which is N/A changed from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Change in Receivables stood at $1.2 million for Q3 2025, which was down 2738.89% from -$992000.0 recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Change in Receivables high stood at $1.6 million for Q3 2024, and its period low was -$1.3 million during Q4 2024.